Related Experiment Videos
Blockade of the specific lethal effects of narcotic analgesics in the mouse
Abstract:
The capacity of the narcotic antagonists naloxone and nalorphine and the benzodiazepine derivatives diazepam and oxazepam to increase the LD50s of the narcotic analgesics morphine and methadone administered at convulsant doses was eveluated in the mouse. Naloxone produced a dose-related increase in the LD50s of both morphine and methadone. Iiazepam and oxazepam were also effective in increasing the LD50s of the narcotics; this effect was additive with that of naloxone. However, the maximal increase in the LD50s of the narcotics produced by pretreatment with naloxone alone was not increased further by the combined pretreatment of naloxone and a benzodiazepine. The anticonvulsant trimethadione did not elevate the LD50s of methadone, nor did it potentiate the effects of naloxone. These results suggest that the benzodiazepines may reduce the lethality of narcotic analgesics administered at high doses by a mechanism other than by an anticonvulsant effect alone. Therefore, the present results support the conclusion that the capacity to increase the convulsant LD50 of the narcotic analgesics is a general property of the narcotic antagonists.
Insights
Narcotic antagonists like naloxone and benzodiazepines such as diazepam can increase the lethal dose 50 (LD50) of narcotic analgesics. This suggests benzodiazepines may reduce narcotic lethality through non-anticonvulsant mechanisms.
Area of Science:
- Pharmacology
- Toxicology
- Neuroscience
Background:
- Narcotic analgesics, such as morphine and methadone, can cause lethal convulsions at high doses.
- Narcotic antagonists are known to reverse opioid effects, but their ability to mitigate high-dose lethality is less understood.
- Benzodiazepines are commonly used for their anticonvulsant properties, but their interaction with narcotic lethality requires further investigation.
Purpose of the Study:
- To evaluate the capacity of naloxone, nalorphine, diazepam, and oxazepam to increase the LD50 of morphine and methadone in mice.
- To determine if benzodiazepines reduce narcotic lethality through anticonvulsant mechanisms.
- To establish whether the ability to increase the convulsant LD50 is a general property of narcotic antagonists.
Main Methods:
- Administered convulsant doses of morphine and methadone to mice.
- Pretreated mice with varying doses of naloxone, nalorphine, diazepam, and oxazepam.
- Assessed the impact of these pretreatments on the LD50 of the narcotic analgesics.
- Included trimethadione as a control anticonvulsant.
Main Results:
- Naloxone significantly increased the LD50 of both morphine and methadone in a dose-dependent manner.
- Diazepam and oxazepam also increased the LD50 of these narcotics, showing an additive effect with naloxone.
- Combined pretreatment with naloxone and benzodiazepines did not further increase the maximal LD50 enhancement.
- Trimethadione did not elevate methadone LD50 or potentiate naloxone's effects.
Conclusions:
- Naloxone and benzodiazepines can increase the LD50 of lethal doses of narcotic analgesics.
- Benzodiazepines may reduce narcotic analgesic lethality via mechanisms beyond simple anticonvulsant activity.
- The capacity to increase the convulsant LD50 of narcotic analgesics appears to be a general characteristic of narcotic antagonists.